Health Care

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.

adminadmin
Sep 18, 2024 - 21:00
 0  12
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read More

Tags:

Previous Article

U.S. crude oil prices fall ahead of pivotal Fed decision on interest rates

Next Article

23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Re...

admin
admin

Related Posts

Waystar shares slip in Nasdaq debut after digital health company priced IPO in middle of range

Waystar shares slip in Nasdaq debut after digital healt...

admin Jun 8, 2024  0  9

Common sugar substitute linked to increased risk of heart attack and stroke

Common sugar substitute linked to increased risk of hea...

admin Jun 6, 2024  0  9

FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

FDA approves Moderna's RSV vaccine for seniors, the com...

admin Jun 1, 2024  0  7